Christopher Counter

Duke University Medical Center, North Carolina, USA

Dr. Counter is the George Barth Geller Distinguished Professor of Pharmacology at Duke University and Associate Director of Basic Research in the Duke Cancer Institute. His laboratory focuses on how oncogenic mutations in RAS the proto-oncogenes initiate tumorigenesis”


13th september
13 September 2023

RAS mutation tropism

13 September
Time:  09:30 - 10:00
Speaker:  Christopher Counter